Comments
Divi’s Laboratories on Wednesday said its Visakhapatnam unit-II received a Form 483 letter from the US Food and Drug Administration. Form 483 is issued to a firm’s management at the conclusion of an inspection where investigators observe any conditions, which in their judgment, may constitute violation of the Food Drug and Cosmetic Act. The US FDA conducted the inspection during November 29 to December 6, Divi’s said.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.